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Abstract
It has previously been shown that apoptosis is increased in ischaemic/reperfused heart. However, little is known about the
mechanism of induction of apoptosis in myocardium during ischaemia. We investigated whether prolonged myocardial
ischaemia causes activation of caspases and whether this activation is related to cytochrome c release from mitochondria to
cytosol during ischaemia. Using an in vitro model of heart ischaemia, we show that 60 min ischaemia leads to a significant
accumulation of cytochrome c in the cytosol and a decrease in mitochondrial content of cytochrome c but not cytochrome a.
The release of cytochrome c from mitochondria was accompanied by activation of caspase-3-like proteases (measured by
cleavage of fluorogenic peptide substrate DEVD-amc) and a large increase in number of cells with DNA strand breaks
(measured by TUNEL staining). Caspase-1-like proteases (measured by YVAD-amc cleavage) were not activated during
ischaemia. Addition of 14 WM cytochrome c to cytosolic extracts prepared from control hearts induced ATP-dependent
activation of caspase-3-like protease activity. Our data suggest that extended heart ischaemia can cause apoptosis mediated
by release of cytochrome c from mitochondria and subsequent activation of caspase-3. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Recent evidence suggests that cardiomyocyte apo-
ptosis can contribute to ischaemia-induced myocar-
dial injury leading to heart failure [1^3]. Apoptosis in
the heart can be induced by variety of stimuli, includ-
ing reactive oxygen species, tumour necrosis factor K,
activation of p53 or c-Jun kinases pathways [4,5].
Many of these pathways are likely to be activated
during reoxygenation rather than during the ischae-
mic period. However, it is unclear whether apoptosis
is induced by ischaemia itself or by reperfusion,
although recent studies show that prolonged hypoxia
by itself is enough to trigger apoptosis in isolated
cardiomyocytes [6,7].
Morphologically apoptosis is characterized by cell
shrinkage, chromatin condensation, DNA fragmen-
tation and plasma membrane blebbing. Several of the
morphological features of apoptosis are caused by
caspase activity, and activation of caspases is often
considered as a key biochemical hallmark of apopto-
sis [8]. Caspases are a family of cysteine proteases
that cleave a variety of cellular substrates after as-
partate residues [8]. In normal living cells, caspases
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are expressed as inactive precursors. When cells are
signalled to die, caspases are activated by proteolytic
cleavage at internal aspartate residue. At present two
pathways of caspase activation are described in the
literature. One is mediated by cell-surface death re-
ceptors (such as Fas or TNF receptors) leading to
autoactivation of caspase-8, which in turn activates
downstream caspases such as caspase-3, -6 and -7
[9,10]. Another pathway is mediated by mitochondria
[11^13]. It has been shown that during apoptosis
mitochondria release several apoptogenic proteins,
such as cytochrome c [11,12] and apoptosis-induc-
ing-factor [14]. Using various cell types, it was shown
that once released into the cytosol cytochrome c
binds to a cytosolic protein Apaf-1 [11^13]. The com-
plex of Apaf-1 and cytochrome c in the presence of
dATP or ATP facilitates activation of caspase-9,
which, in turn, promotes processing of caspase-3 to
its active form [15]. Thus, caspase-3 can be activated
by mitochondria-mediated processes or directly by
caspase-8. At present it is not clear which pathway
is involved in initiation of apoptosis in ischaemia-
damaged myocardium.
Our previous studies on isolated mitochondria and
skinned cardiac ¢bres have shown that loss of cyto-
chrome c from mitochondria occurs during the early
reversible phase of ischaemia [16]. These observa-
tions raise the possibility that ischaemia-induced re-
lease of cytochrome c from mitochondria might
cause activation of caspase-3 in myocardial cells
leading to apoptosis. In the present study we demon-
strate that prolonged total myocardial ischaemia
causes accumulation of cytochrome c in the cytosol,
increase in activity of caspase-3-like proteases and
fragmentation of nuclear DNA. Our data suggest
that ischaemia-induced apoptosis in myocardium
might be mediated by mitochondria via release of
cytochrome c to the cytosol. Some of these ¢ndings
have been reported in a preliminary form elsewhere
[17].
2. Materials and methods
2.1. Experimental model
Hearts from male Wistar rats were used in experi-
ments. In vitro total ischaemia was induced by au-
tolysis as described previously [18]. Brie£y, the hearts
were washed free of blood in warm (37‡C) 0.9% KCl
solution, placed in a humidi¢ed chamber maintained
at 37‡C, and allowed to autolyse for 15, 30 or 60 min.
2.2. Preparation of cytosolic and mitochondrial
fractions of myocardial tissue
Hearts were cut into small pieces and homogenized
in the medium (5 ml/1 g of tissue) containing 300 mM
sucrose, 20 mM Tris^HCl, 1 mM EGTA (pH 7.4).
Cytosolic and mitochondrial fractions were separated
by di¡erential centrifugation (5 min at 1000Ug,
10 min at 9000Ug). Post-mitochondrial supernatant
was additionally centrifuged for 60 min at 100 000Ug
and the resulting supernatant (S100) was used for
determination of caspase activity and immunoblot-
ting. Total cytosolic and mitochondrial protein was
measured by a modi¢ed micro-Lowry (Sigma Protein
Assay kit) or Bradford (Sigma) methods.
2.3. Measurement of caspase and citrate synthase
activity
Activity of caspases was measured using £uoro-
genic substrate peptides (YVAD-amc, DEVD-amc,
IETD-amc). Fifty Wg of cytosolic protein were incu-
bated with 100 WM substrate peptide in 50 Wl of
incubation bu¡er (50 mM HEPES, 10% sucrose,
1 mM MgCl2, 1 mM DTT, pH 7.4) at 37‡C for
60 min, and release of amino-methyl-coumarin
(amc) was measured using a Perkin^Elmer £uorime-
ter (excitation at 380 nm, emission at 460 nm). Ten
nM amc was used as standard.
Activity of citrate synthase in total homogenate,
cytosolic and mitochondrial fractions (solubilized
with 1% Triton X-100) was determined by a spectro-
photometric method [19].
2.4. Measurement of cytochrome c in mitochondria
Total cytochrome c and cytochrome a content was
determined in mitochondria solubilized with 1% Tri-
ton X-100 (w/v). The ascorbate-reduced-minus-ferri-
cyanide-oxidized absorbtion di¡erence spectrum was
recorded with a Hitachi U-2000 spectrophotometer.
Cytochrome c content was estimated by using the
absorbtion di¡erence at the wavelength pair 550/
BBADIS 62048 6-9-01 Cyaan Magenta Geel Zwart
V. Borutaite et al. / Biochimica et Biophysica Acta 1537 (2001) 101^109102
535 nm and A= 14.5 mM31 cm31 ; for cytochrome a
wavelength pair 605/630 nm and A= 10.4
mM31 cm31 as described in [20].
2.5. Western blot analysis
For detection of cytochrome c and cytochrome
oxidase in cytosolic fractions samples were boiled
and subjected to electrophoresis on 15% sodium do-
decyl sulphate^polyacrylamide gels. Proteins were
electrotransferred to nitrocellulose membrane using
a semi-dry blotter. Membranes were blocked over-
night at 4‡C in TBST (50 mM Tris^HCl, 150 mM
NaCl, 0.1% Tween 20, pH 7.5) containing 3% bovine
serum albumin and then were incubated with pri-
mary monoclonal antibodies to denatured cyto-
chrome c (1:500, PharMingen) or to cytochrome oxi-
dase subunit IV (1:500; Molecular Probes). After
washing in TBST membranes were incubated with
secondary anti-mouse Ig antibody conjugated with
horseradish peroxidase (1:5000, Jackson Immuno-
Research Laboratories). Blots were detected using
ECL Western blotting detection reagents (Amersham
Pharmacia Biotech). Band intensities were analysed
using densitometer.
2.6. Evaluation of apoptosis
The number of apoptotic cells was quanti¢ed by
dUTP nick end labelling (TUNEL) using APOP
TAG (Oncor) or CardioTACS (RpD Systems) in
situ apoptosis detection kits. In brief, control and
ischaemic heart tissues were ¢xed in 10% formalin.
The tissues were carefully embedded in molten par-
a⁄n and frozen. Between six and ten sections were
made from each heart ventricles. Prior to analysis,
tissue sections were depara⁄nized with xylene and
washed with di¡erent concentrations of ethanol (ab-
solute, 95%, 70%). Then sections were treated with
proteinase K for 15 min at room temperature. All
other procedures were performed according to the
manufacturer’s protocol. The cells with 3P-OH
DNA ends generated by DNA fragmentation
(TUNEL-positive cells) were visualized by light
microscope. The number of TUNEL-positive cardio-
myocytes were counted in at least ¢ve di¡erent
microscopic ¢elds on each section containing approx-
imately 200 cardiomyocytes in each.
3. Statistical analysis
Data are expressed as means þ S.E. of at least
three separate experiments. Statistical comparison
between experimental groups was performed using
Student’s t-test.
4. Results
4.1. Myocardial ischaemia causes activation of
caspase-3- but not caspase-1- or -8-like proteases
We investigated whether prolonged heart ischae-
mia causes activation of caspases. For this, aliquots
of cytosolic extracts were incubated for the indicated
time with speci¢c synthetic £uorogenic substrate pep-
tides: DEVD-amc for caspase-3-like proteases (in-
cluding caspase-2, -3 and -7), YVAD-amc for cas-
pase-1- (including caspase-1, -4 and -5) and IETD-
amc mainly for caspase-8-like proteases (but also
caspase-6 and -9) [8]. Increase in £uorescence due
to cleavage of substrate peptide DEVD-amc by cas-
pases was close to linear during 2 h of incubation
(data not shown) indicating that caspases were al-
ready activated in ischaemic myocardium and no sig-
Table 1
Activity of caspase-1- and caspase-8-like proteases in control and ischaemic heart cytosolic extracts
Control 15 min ischaemia 30 min ischaemia 60 min ischaemia
YVAD-cleaving activity 0.021 þ 0.001 ^ ^ 0.024 þ 0.005
IETD-cleaving activity 0.221 þ 0.028 0.222 þ 0.039 0.176 þ 0.013 0.128 þ 0.026
Activities of caspases in control and ischaemic cytosols were determined from 50 WM BAF- or 10 WM IETD-CHO-inhibitable increase
of £uorescence after 60 min of incubation with appropriate caspase substrate^peptide: YVAD-amc for caspase-1- and IETD-amc for
caspase-8-like proteases. Activity of caspases is expressed as nmol of amc/min per mg cytosolic protein. Values are mean þ S.E. Data
shown are from three to ¢ve independent experiments for each treatment.
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ni¢cant activation occurred during in vitro incuba-
tion with synthetic substrates. Thus, in further ex-
periments we measured £uorescence after 60 min of
incubation with substrate peptides. Increase in £uo-
rescence was inhibited by the broad-spectrum cas-
pase inhibitor BAF, boc-aspartyl(O-methyl)£uoro-
methylketone, (data not shown), con¢rming that
substrate^peptide cleavage was caused by caspases
but not by other proteases.
YVAD-cleaving activity was found to be very low
in control as well as in cytosols from ischaemic
hearts (Table 1). IETD-cleaving activity, though sig-
ni¢cantly higher in control, did not increase during
ischaemia (Table 1). This indicates that both caspase-
1- and caspase-8-like proteases were not activated
during 60 min of myocardial ischaemia. In contrast,
the DEVD-cleaving activity was low in control
(0.036 þ 0.012 nmol/min per mg protein) but progres-
sively increased during ischaemia reaching a value of
0.198 þ 0.044 nmol/min per mg protein after 60 min
of ischaemia (Fig. 1). These results indicate that ac-
tivation of caspase-3-like proteases occurs in ischae-
mic myocardium.
4.2. Prolonged myocardial ischaemia causes
accumulation of cytochrome c in the cytosol
In our previous paper [16], using isolated mito-
chondria and skinned cardiac ¢bres we have shown
that an increase in mitochondrial outer membrane
permeability to cytochrome c and a decrease in the
mitochondrial content of cytochrome c are early
events during ischaemia. The decrease in mitochon-
drial cytochrome c during ischaemia might be due to
its proteolytic degradation or release into cytosol. To
test whether cytochrome c, released from mitochon-
dria during ischaemia, accumulates in the cytosol we
measured cytochrome c in mitochondrial and cyto-
solic fractions prepared from control and ischaemic
hearts. Data presented in Fig. 2A show that there
was no change in mitochondrial cytochrome a con-
tent after 60 min of ischaemia, but the amount of
cytochrome c in ischaemic mitochondria was de-
creased as compared to control level. The ratio of
Fig. 2. Myocardial ischaemia causes release of cytochrome c
from mitochondria to the cytosol. (A) Mitochondrial content of
cytochromes c and a in control and ischaemia-damaged isolated
mitochondria. Content of cytochromes c and a in isolated mito-
chondria was determined spectrophotometrically from reduced-
minus-oxidized spectra of cytochromes. (B) Cytochrome c con-
tent in cytosolic fractions from control and ischaemic hearts.
Cytochrome c content was determined by Western blot analysis.
*P6 0.001 as compared to control.
Fig. 1. E¡ect of ischaemia on activity of caspase-3-like pro-
teases. DEVD-cleaving activity in control and ischaemic cyto-
sols was determined from BAF-inhibitable increase of £uores-
cence after 60 min incubation. In some experiments 10 WM
DEVD-CHO instead of BAF was used as inhibitor of caspase-
3-like proteases. Values are means þ S.E. Data shown are from
four to eight independent experiments for each treatment (con-
trol or various duration heart ischaemia). *Statistically signi¢-
cant (P6 0.01) e¡ect of ischaemia as compared to control.
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mitochondrial content of cytochrome c to cyto-
chrome a after ischaemia was decreased by about
35%, indicating that only part of cytochrome c was
released. For measurement of cytochrome c levels in
cytosols we used Western blots, as heart cytosol con-
tains myoglobin, the spectrum of which interferes
with the cytochrome c spectrum. As can be seen in
Fig. 2B and Fig. 3, prolonged ischaemia led to a
substantial increase in cytochrome c level in cytosols.
Cytochrome c in cytosols increased 2.6 times after 60
min of ischaemia, whereas there was no statistically
signi¢cant change during 15^30 min of ischaemia
(Fig. 2B). Together these results indicate that during
ischaemia there is a speci¢c release of cytochrome c
from mitochondria into cytosol rather than general
degradation of mitochondrial cytochromes.
The homogenization procedure of heart tissue
rather than ischaemia itself might a¡ect integrity of
mitochondrial membranes therefore causing loss of
cytochrome c from mitochondria. This may explain
why low levels of cytochrome c were always present
even in control cytosols. To evaluate any damage
caused by homogenization to mitochondria we mea-
sured the activity of the mitochondrial-matrix en-
zyme citrate synthase in total homogenates, cytosolic
fractions and isolated mitochondria from control and
ischaemic hearts. We found that 60 min of ischaemia
had no signi¢cant e¡ect on citrate synthase activity
in total homogenates (5.04 þ 0.62 and 4.0 þ 0.68
nmol/min per Wl homogenate in control and 60 min
ischaemia) and mitochondria (635 þ 70 and 758 þ 170
nmol/min per mg protein, respectively), indicating
that this enzyme is not damaged during ischaemia.
After removal of the mitochondrial fraction by cen-
trifugation there still was some residual activity of
citrate synthase in cytosolic fractions in control as
well as in ischaemic samples. The activity was similar
in control and ischaemia (0.91 þ 0.32 and 0.75 þ 0.13
nmol/min per Wl homogenate in control and 60 min
ischaemia), thus indicating that release of mitochon-
drial matrix proteins into the cytosolic fraction was
similar for control and ischaemic hearts. Similar re-
sults were obtained from Western blot analysis of
cytochrome c oxidase subunit IV (COX), which is
another marker for intactness of the mitochondrial
inner membrane. The levels of COX were undetect-
able in all samples using the same amount of total
protein as for detection of cytochrome c, but could
be visualized when total protein concentration used
for Western blots was increased about 8 times (Fig.
3). COX levels were found to be similar in cytosolic
fractions from control and ischaemic hearts (Fig. 3),
indicating that control and ischaemic mitochondria
were damaged to the same extend by the isolation
procedure. Since ischaemia did not cause an increase
in cytosolic citrate synthase activity or level of COX
in cytosolic fractions it follows that ischaemia did
not cause a general disruption of mitochondrial
membranes, and therefore a general disruption was
not responsible for the ischaemia-induced cyto-
chrome c release.
4.3. Caspase-3-like activity in the cytosol from control
heart can be activated by added cytochrome c
It has been established that activation of caspase 3
can be initiated in vitro by the addition to cytosolic
extracts of cytochrome c together with dATP or ATP
[13,21]. We used a similar in vitro system to examine
whether cytochrome c causes activation of caspase-3-
like proteases in cytosols from normal, non-ischae-
mic hearts. Though a small amount of cytochrome c
was usually present in control cytosols due to possi-
ble rupture of mitochondria during homogenization
of tissue, this was not enough to cause substantial
activity of caspase-3 during the relatively short time
Fig. 3. Representative Western blots for cytochrome c and cyto-
chrome oxidase (COX) in cytosolic extracts from control and
ischaemic hearts. Lane 1, samples from control heart; lanes 2^
4, samples from 15-, 30- and 60-min ischaemic hearts, respec-
tively. 0.8 Wg of total protein was loaded on each lane for im-
munoblotting of cytochrome c, and 0.8 Wg or 5 Wg for COX.
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of incubation (60^120 min). However, 60 min prein-
cubation with 14 WM exogenous cytochrome c was
su⁄cient to trigger ATP-dependent induction of cas-
pase-3-like protease activity in control cytosols:
DEVD-amc-cleaving activity, though variable from
experiment to experiment, was increased from
0.031 þ 0.007 nmol/min per mg protein in control to
0.181 þ 0.064 nmol/min per mg protein in the pres-
ence of added cytochrome c. These results indicate
that cytochrome c in the presence of ATP is able to
mediate activation of caspase-3-like proteases in con-
trol cytosolic extracts.
4.4. Myocardial ischaemia causes fragmentation of
nuclear DNA
To further characterize apoptosis in ischaemic my-
ocardium, we used the TUNEL method to determine
cells with DNA strand breaks. As can be seen from
Fig. 4, cardiomyocytes with DNA strand breaks were
practically not detectable in control hearts
(0.116 þ 0.074% of total number of cells) ; however,
the number of such cells increased signi¢cantly dur-
ing ischaemia and after 60 min of ischaemia there
were 3.90 þ 1.25% of TUNEL-positive cells
(P6 0.01 if compared to control). The TUNEL
method can detect DNA strand breaks in the late
stages of necrosis as well as in apoptotic cells. How-
ever, activation of caspases is considered as a hall-
mark of apoptosis. In our experiments, the time of
appearance of cardiomyocytes with DNA strand
breaks was similar to that of caspase-3-like protease
activation during ischaemia (compare to Fig. 1). Al-
together these data suggest that prolonged ischaemia
can induce apoptosis in the myocardium.
5. Discussion
We have used an in vitro model of heart ischaemia
to show that extended ischaemia (without normo-
thermic reperfusion) can cause: the loss of mitochon-
drial cytochrome c (with no change in cytochrome
a) ; the accumulation of cytochrome c in the cyto-
plasm (with no release of mitochondrial citrate syn-
thase); activation of caspase-3-like activity (with no
increase in caspase-1 or caspase-8 like activities); and
the fragmentation of nuclear DNA, suggestive of
apoptosis. Addition of cytochrome c (in the presence
of ATP) activated caspase-3 like activity in the cyto-
sol from control hearts, suggesting that the release of
cytochrome c into the cytosol during ischaemia
may be su⁄cient to explain the increase in caspase-
3 activity. However, we do not know whether the
cytochrome c release was quantitatively su⁄cient to
explain the caspase-3 activation, and thus it is possi-
ble that there are other mechanisms contributing to
caspase-3 activation. We can make a semi-quantita-
tive estimate of whether the cytochrome c released
would be su⁄cient to activate the caspases based on
our ¢nding that 14 WM added cytochrome c caused
Fig. 4. Ischaemia causes strand breaks in nuclear DNA. Car-
diomyocytes with TUNEL-positive nuclei were determined in
sections of control (A) and 60-min ischaemic (B) hearts as de-
scribed in Section 2 (U1000). Only cells with clear myocyte
morphology were counted.
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activation of caspase activity in the control cytosol,
and an estimate of the amount of cytochrome c re-
leased. The amount of cytochrome c in adult rat
heart has been measured to be 0.4^0.5 mg/g wet
weight of heart [22]. If the molecular mass of cyto-
chrome c is 12 500 and the amount of free water in
heart is 0.7 ml/g, then this is equivalent to a cyto-
chrome c concentration of about 50 WM in whole
heart. If 35% of this is released from mitochondria
into the cytosol then the concentration of cyto-
chrome c in the cytosol will be at least 17.5 WM.
We found that 14 WM added cytochrome c was suf-
¢cient to activate the caspases in vitro. Thus if a
similar concentration were su⁄cient to cause caspase
activation in vivo, then the release of 35% of mito-
chondrial cytochrome c would be su⁄cient to cause
caspase activation in vivo.
We do not know what caused the ischaemia-in-
duced cytochrome c release, but it does not appear
to be due to general disruption of the mitochondria
since (a) ischaemia did not cause any change in the
mitochondrial or cytosolic level of cytochrome oxi-
dase, a marker of the mitochondrial inner mem-
brane, and (b) ischaemia did not signi¢cantly change
the distribution of mitochondrial citrate synthase, a
marker of the mitochondrial matrix. We have previ-
ously shown using this in vitro model that extended
ischaemia causes a marked increase in mitochondrial
calcium [16], and that calcium (or oxidant) addition
to mitochondria isolated from control hearts causes
cytochrome c release which was inhibitable by cyclo-
sporin A, and thus probably due to opening of the
permeability transition pore (inhibitable by cyclo-
sporin A) [23]. Mitochondrial swelling has been
shown by electron microscopy to start after 15 min
of heart ischaemia and after 60 min of ischaemia
most mitochondria in myocardium are swollen (see
[24] for review). Thus a possible scheme of events
is : ischaemiaCrise in cell calcium (and phosphate)
Copening of the permeability transition poreCcy-
tochrome c releaseCcaspase-3 activation. Strong
supporting evidence for heart ischaemia-induced cy-
tochrome c release and caspase activation comes
from the recent ¢nding that 1 h hypoxia in isolated
adult rat cardiomyocytes causes redistribution of cy-
tochrome c to cytosol and proteolytic cleavage of
caspase-3 [7]. In contrast Kang et al. [25] found
that 6 h of hypoxia in isolated cardiomyocytes
caused no cytochrome c release, caspase activation
and annexin staining, but these changes were acti-
vated by 6^12 h of reoxygenation. Similarly Zhaock
et al. [26] found that 7 h of heart ischaemia in vivo in
dogs caused no TUNEL staining of heart cells or
DNA laddering, whereas 1 h of ischaemia followed
by 6 h of reperfusion caused both signs of apoptosis.
Thus, these di¡erent models give strikingly di¡erent
conclusions as to whether ischaemia itself is su⁄cient
to induce apoptosis in the heart. Others have pro-
vided evidence that the permeability transition pore
may open during reperfusion [27,28], but it is unclear
whether this may occur during ischaemia itself. Cer-
tain apoptosis-inducing peptides (such Bax, Bad and
Bid) can apparently cause cytochrome c release in the
absence of permeability transition [29^31]. It is also
possible that the cytochrome c release was a conse-
quence, rather than a cause, of caspase-3 activation,
since it has been reported that addition of caspases
to isolated mitochondria can cause cytochrome c re-
lease [32], possibly by cleavage of Bcl-2 [33,34]. How-
ever, recent data from R.N. Kitsis’ laboratory [35]
show that poly-caspase inhibitor zVAD-fmk blocks
caspase processing, but not cytochrome c release
from mitochondria in primary culture of cardiac my-
ocytes deprived of serum and glucose, components of
ischaemia in vivo, placing the release of cytochrome
c upstream of caspase activation.
It is possible that the apparent loss of mitochon-
drial cytochrome c and appearance of cytochrome c
in the cytosolic fraction was an artefact due to mi-
tochondria from the ischaemic heart being more
fragile than those from control heart, such that
they were more liable to rupture during preparation.
However, we think this unlikely since we found no
di¡erence in the content of cytochrome a (a mito-
chondrial inner membrane protein) or citrate syn-
thase (a matrix protein) in ischaemic and control
mitochondria.
Another possibility is that the cytochrome c release
and caspase-3 activation did not occur during the
ischaemic period, but rather the ‘reperfusion’ period
of heart homogenization and preparation of the mi-
tochondrial and cytosolic fractions. We think this
unlikely because the procedure was carried out at
4‡C, in the presence of EGTA (a calcium chelator),
which should prevent any potential activation of the
permeability transition during homogenization of the
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ischaemic heart. A similar procedure was shown to
close mitochondrial permeability transition pore
opened during myocardial ischaemia/reperfusion
[28]. It has previously been shown that reperfusion
damage occurs during the transition from hypother-
mic ischaemia to normothermia, but not during hy-
pothermic reperfusion of ischaemic liver, suggesting
that the permeability transition induced by reperfu-
sion does not occur at 4‡C [36].
TUNEL staining is extensively used as a marker of
apoptosis, but can in some cases occur in the absence
of apoptosis if there is extensive DNA damage dur-
ing necrosis [37,38]. If we take the TUNEL staining
as a quantitative measure of apoptosis, then 0.1% of
heart cells were apoptotic in the control hearts and
about 4% after 60 min ischaemia. This time course
was similar to that of caspase-3 activation, and cas-
pase-3 is known to activate DNA fragmentation by
cleavage of ICAD/CAD DNAases [39]. Since cas-
pase-3 activity and the number of apoptotic cells is
still rising at 60 min of ischaemia, if the heart were to
be reperfused at 60 min the level of apoptosis is likely
to continue to rise (unless reperfusion itself were able
to block caspase-3 activity or its consequences ^
which seems unlikely).
It is unclear whether intervention to block apopto-
sis with caspase inhibitors at reperfusion would be
bene¢cial to the heart, as those cells that have re-
leased cytochrome c and triggered apoptosis may
then go on to necrosis, which might cause more dam-
age to surrounding cells than apoptosis. We have
previously shown that the release of cytochrome c
during ischaemia severely inhibits the respiratory
function of the mitochondria [16], which might
contribute to malfunction of the heart after ischae-
mia and to subsequent necrosis. However, there is
evidence that caspase inhibitors can help preserve
heart function subsequent to ischaemia/reperfusion
[40,41].
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